Adolescent Drug Abuse MDFT Case Study (Part 1 of 2)
Adolescent Drug Abuse MDFT Case Study (Part 1 of 2) – This is a presentation of a typical MDFT case. It is Part 1 of 2. To see additional videos, including part two of this case presentation, please go to our YouTube channel (www.youtube.com ), or go directly to the videos using the following links: (1) Multidimensional Family Therapy, An Introduction (Part 1 of 2) www.youtube.com (2) Multidimensional Family Therapy, An Introduction (Part 2 of 2) www.youtube.com (3) Risk and Protective Factors www.youtube.com (4) MDFT – Juvenile Justice www.youtube.com (5) Adolescent Treatment www.youtube.com (6) Adolescent Drug Abuse MDFT Case Study (Part 1 of 2) www.youtube.com (7) Adolescent Drug Abuse MDFT Case Study (Part 2 of 2) www.youtube.com (8) Future of Adolescent Treatment and Research www.youtube.com (9) Dr. Howard Liddle, Multidimensional Family Therapy DVD (APA Video Series) www.youtube.com (10) MDFT (Multidimensional Family Therapy, in Dutch with English subtitles) www.youtube.com (11) MDFT (Multidimensional Family Therapy, Dutch version) www.youtube.com (12) MDFT (Multidimensional Family Therapy, German version) www.youtube.com About Dr. Howard Liddle: Howard A. Liddle, EdD, ABPP (Family Psychology), is Professor, in the Departments of Epidemiology and Public Health and Psychology, and Director, of the Center for Treatment Research on Adolescent Drug Abuse at the University of Miami Miller School of Medicine (www.miami.edu\ctrada).Trained as a psychologist and family therapist, Dr. Liddle directs a long term program of …
Improved HIV Care Boosts Life Expectancy at Clinic, Study Found
Filed under: drug abuse treatment outcome study
28 (HealthDay News) — Treatment advances, a multifaceted treatment approach and federal funding helped improve care and outcomes for all HIV patients at an inner-city clinic in Baltimore, including those often hit hardest by the disease, researchers …
Read more on U.S. News & World Report
Intarcia to Present Analysis of Dose Selection for Global ITCA 650 Phase 3 …
Filed under: drug abuse treatment outcome study
28, 2012 — /PRNewswire/ — Intarcia Therapeutics, Inc. announced that an analysis of the results of a phase 2 clinical study of ITCA 650 (continuous subcutaneous delivery of exenatide) for the treatment of type 2 diabetes will be presented at the 48th …
Read more on Sacramento Bee